Ticker Report CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - HC Wainwright lifted their Q3 2024 earnings per share estimates for shares of CollPlant Biotechnologies in a report released on Wednesday...\n more…
Ticker Report CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - Stock analysts at HC Wainwright lowered their FY2027 earnings per share (EPS) estimates for CollPlant Biotechnologies in a research note...\n more…
Ticker Report HC Wainwright reissued their buy rating on shares of CollPlant Biotechnologies (NASDAQ:CLGN - Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a...\n more…
Benzinga Throughout the last three months, 4 analysts have evaluated CollPlant Biotechnologies CLGN, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.\n more…
Seeking Alpha - Israel Stocks CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript...\n more…